thus, larger and longer randomised clinical trials, such as the SURPASS-CVOT trial, are essential to fully evaluate the potential clinical advantages of dual GLP-1/GIP agonists compared with GLP-1 receptor agonists
Taking all of this into account, I believe a fair value multiple for $HIMS is closer to 30x forward EV/EBITDA , which would imply a share price of around $40
Disclaimer: Always consult a healthcare professional before adjusting dosage or beginning any new supplement
Multidisciplinary GI care, which brings together specialized clinicians, dietitians, and behavioral health support, can help patients identify the drivers of their symptoms and manage them, so they can stay on the treatments that work for them
Gentle scalp massage improves blood circulation to hair follicles, whilst specialised hair products containing caffeine, niacinamide, or peptides can create an optimal environment for regrowth